相关实验视频
Updated: Jun 15, 2025
08:06
Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues
Published on: July 8, 2020
5.5K
利基里通过调节YY1/RBP3轴来进行牛皮治疗和预防
Guoshu Deng1, Yulin Zhang1, Jiankun Song2
1Department of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China.
概括
液化素 (LIQ) 通过向YY1/RBP3轴,有效治疗和预防牛皮. 这项研究揭示了LIQQ.
科学领域:
- 皮肤病学和药理学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 牛皮 (PSO) 是一个全球性的健康问题,具有显著的复发率.
- 液化素 (LIQ) 是由Glycyrrhiza inflata Batalin衍生而来的,具有抗炎症和抗增殖的特性.
- 在PSO治疗和预防中,LIQ的精确治疗机制尚不清楚.
研究的目的:
- 研究LIQ在治疗和预防牛皮的潜力.
- 阐明LIQ在PSO中的作用的基础分子机制.
主要方法:
- 使用HaCaT细胞进行体外研究,以评估LIQ的抗炎和抗增殖作用.
- 转录和生物信息分析以确定目标基因和调节途径.
- 在imiquimod诱导的类似牛皮的小鼠模型中进行体内验证,以评估治疗和预防疗效.
- 机理学研究包括化酶记者测定和ChIP-PCR.
主要成果:
- 视网醇结合蛋白3 (RBP3) 被确定为一个核心目标,YY1作为它的上游转录因子.
- YY1/RBP3轴在体外和体内被LIQ调节.
- 在小鼠模型中,LIQ显著抑制了牛皮的进展和预防了牛皮复发.
- LIQ增强了YY1和RBP3之间的结合亲和力,阐明了它的机制.
结论:
- YY1/RBP3轴代表了牛皮的潜在治疗目标.
- LIQ被确定为治疗和预防牛皮的有希望的候选人.
更多相关视频
相关概念视频
01:24T Cell Types and Functions
963
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
963
01:22iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K